Dilation Capital Management’s ASML ASML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.46M Sell
3,015
-2,455
-45% -$4.26M 2.73% 15
2026
Q2
$10.9M Sell
5,470
-85
-2% -$135K 4.39% 10
2026
Q1
$7.34M Buy
+5,555
New +$7.61M 3.68% 14

Other funds holding ASML

Dilation Capital Management's ASML Position: Q3 2026 in Review

Dilation Capital Management reduced its ASML (ASML) stake by 45% in Q3 2026, selling an estimated $4.26M and leaving 3,015 shares worth $5.46M. The position accounts for 2.73% of the portfolio, ranked #15.

Dilation Capital Management first reported a position in ASML in Q1 2026 and has held it in 3 quarters since. The position peaked at $10.9M in Q2 2026. 671 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Dilation Capital Management held 3,015 shares of ASML worth $5.46M as of Q3 2026.
  • Dilation Capital Management sold 2,455 ASML shares in Q3 2026, an estimated $4.26M.
  • ASML made up 2.73% of Dilation Capital Management's portfolio in Q3 2026, its #15 holding.
  • Dilation Capital Management first reported a position in ASML in Q1 2026 and has held it in 3 quarters since.
  • Dilation Capital Management's ASML position peaked at $10.9M in Q2 2026.
  • 671 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Dilation Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.